Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcome.
Somlo G, Doroshow JH, Synold T, Longmate J, Reardon D, Chow W, Forman SJ, Leong LA, Margolin KA, Morgan RJ Jr, Raschko JW, Shibata SI, Tetef ML, Yen Y, Kogut N, Schriber J, Alvarnas J. Somlo G, et al. Among authors: alvarnas j. Br J Cancer. 2001 Jun 15;84(12):1591-8. doi: 10.1054/bjoc.2001.1835. Br J Cancer. 2001. PMID: 11401310 Free PMC article. Clinical Trial.
Prognostic indicators and survival in patients with stage IIIB inflammatory breast carcinoma after dose-intense chemotherapy.
Somlo G, Frankel P, Chow W, Leong L, Margolin K, Morgan R Jr, Shibata S, Chu P, Forman S, Lim D, Twardowski P, Weitzel J, Alvarnas J, Kogut N, Schriber J, Fermin E, Yen Y, Damon L, Doroshow JH. Somlo G, et al. Among authors: alvarnas j. J Clin Oncol. 2004 May 15;22(10):1839-48. doi: 10.1200/JCO.2004.10.147. J Clin Oncol. 2004. PMID: 15143076
Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell cancer.
Margolin KA, Doroshow JH, Frankel P, Chow W, Leong LA, Lim D, McNamara M, Morgan RJ, Shibata S, Somlo G, Twardowski P, Yen Y, Kogut N, Schriber J, Alvarnas J, Stalter S. Margolin KA, et al. Among authors: alvarnas j. Biol Blood Marrow Transplant. 2005 Nov;11(11):903-11. doi: 10.1016/j.bbmt.2005.07.010. Biol Blood Marrow Transplant. 2005. PMID: 16275593 Free article. Clinical Trial.
Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer.
Morgan RJ, Doroshow JH, Leong L, Schriber J, Shibata S, Forman S, Hamasaki V, Margolin K, Somlo G, Alvarnas J, McNamara M, Longmate J, Raschko J, Chow W, Vasilev S, McGonigle K, Yen Y. Morgan RJ, et al. Among authors: alvarnas j. Bone Marrow Transplant. 2001 Nov;28(9):859-63. doi: 10.1038/sj.bmt.1703243. Bone Marrow Transplant. 2001. PMID: 11781646 Clinical Trial.
Phase-2 trial of an intensified conditioning regimen for allogeneic hematopoietic cell transplant for poor-risk leukemia.
Stein AS, O'Donnell MR, Synold TW, Dagis AC, Tsirunyan A, Nademanee AP, Parker PM, Pullarkat VA, Snyder DS, Spielberger RT, Wong JY, Alvarnas JC, Thomas SH, Forman SJ. Stein AS, et al. Among authors: alvarnas jc. Bone Marrow Transplant. 2011 Sep;46(9):1256-62. doi: 10.1038/bmt.2010.295. Epub 2010 Dec 13. Bone Marrow Transplant. 2011. PMID: 21151180 Free PMC article. Clinical Trial.
Does follicularity in large cell lymphoma predict outcome after autologous stem cell transplantation?
Krishnan A, Nademanee A, Fung H, Angelopoulou M, Molina A, Gaal K, Dagis A, Palmer J, Alvarnas J, Slovak M, Kogut N, Popplewell L, Rodriguez R, Schriber J, Wang S, Forman SJ. Krishnan A, et al. Among authors: alvarnas j. Biol Blood Marrow Transplant. 2006 Jun;12(6):641-7. doi: 10.1016/j.bbmt.2005.12.040. Biol Blood Marrow Transplant. 2006. PMID: 16737937 Free article.
61 results